Skip to main content
. 2023 Nov 4;73(6):522–530. doi: 10.1007/s13224-023-01859-4

Table 3.

Major systems involved in the study population

S. NO Major Systems Involved Pregnancy N = 112 Post-partum N = 16 Total N = 128 Percentage (%)
I Hypertensive Disorders of Pregnancy 25 8 33 25.7
Severe Preeclampsia 7 1 8
HELLP syndrome 5 1 6
Eclampsia 13 6 17
II Cardiovascular disease 29 0 29 22.6
Valvular heart disease 12 12
Congenital heart disease 5 5
Prosthetic heart valve 5 5
Pulmonary artery hypertension 4 4
Cardiomyopathy 2 2
Heart block 1 1
II Neurological Disease 14 2 16 12.5
Seizure disorder 7 7
Intracranial haemorrhage 0 1 1
Meningoencephalitis 1 1
GBS (Guillain–Barre syndrome) 2 2
Cerebral venous thrombosis 1 1 2
Quadriparesis—Barter’s syndrome 1 1
Transverse myelitis 1 1
Idiopathic intracranial hypertension 1 1
IV Infectious Disease 9 3 12 9.4
COVID-19 5 5
Dengue 2 2
Sepsis 1 3 4
Cellulitis 1 1
V Haematological Disease 9 2 11 8.6
Pancytopenia 4 4
ITP (Ideopathic Thrombocytopenia) 3 3
DIC (Disseminated intravascular Coagulation) 0 2 2
Severe anaemia 1 1
VI Gastrointestinal disease 8 1 9 7.1
Chronic liver disease 2 2
Non-cirrhotic portal fibrosis 4 4
Acute Fatty Liver of Pregnancy (AFLP) 1 1 2
Pancreatitis 1 1
VII Connective tissue disorder 7 0 7 5.4
Systemic Lupus Erythematosus 6 6
Takayasu arteritis 1 1
VIII Renal disease—CKD 6 0 6 4.7
IX Endocrinological disorder 4 0 4 3.1
Diabetic Ketoacidosis 2 2
Hyperthyroidism 1 1
Primary adrenal insufficiency 1 1
X Poisoning (oleander seed) 1 0 1 0.8